Skip to main content
Nature Portfolio logoLink to Nature Portfolio
. 2024 Jun 17;5(7):1130. doi: 10.1038/s43018-024-00797-y

Author Correction: Direct and selective pharmacological disruption of the YAP–TEAD interface by IAG933 inhibits Hippo-dependent and RAS–MAPK-altered cancers

Emilie A Chapeau 1,, Laurent Sansregret 1, Giorgio G Galli 1, Patrick Chène 1, Markus Wartmann 1, Thanos P Mourikis 1, Patricia Jaaks 1, Sabrina Baltschukat 1, Ines A M Barbosa 1, Daniel Bauer 1, Saskia M Brachmann 1, Clara Delaunay 1, Claire Estadieu 1, Jason E Faris 2, Pascal Furet 1, Stefanie Harlfinger 1,3, Andreas Hueber 1, Eloísa Jiménez Núñez 1, David P Kodack 2, Emeline Mandon 1, Typhaine Martin 1, Yannick Mesrouze 1, Vincent Romanet 1, Clemens Scheufler 1, Holger Sellner 1, Christelle Stamm 1, Dario Sterker 1, Luca Tordella 1, Francesco Hofmann 1,4, Nicolas Soldermann 1, Tobias Schmelzle 1,
PMCID: PMC11286518  PMID: 38886525

Correction to: Nature Cancer 10.1038/s43018-024-00754-9, published online 2 April 2024

In the version of the article initially published, in Fig. 1f, the MSTO-211H graph was originally a duplicate of NCI-H226. This has now been amended, and the correct MSTO-211H graph can be found in the HTML and PDF versions of the article.

Contributor Information

Emilie A. Chapeau, Email: emilie.chapeau@novartis.com

Tobias Schmelzle, Email: tobias.schmelzle@novartis.com.


Articles from Nature Cancer are provided here courtesy of Nature Publishing Group

RESOURCES